Stay updated on Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a Locations section with Maryland as a site. Removed the HHS Vulnerability Disclosure and Maryland Locations entries, and updated the revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. The change is cosmetic and does not alter study details or how the page functions.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded explicit notes that publications are provided voluntarily by the entering party and may be auto-filled from PubMed, and included a Revision: v3.3.1; the previous wording about PubMed-derived publications was updated.SummaryDifference0.2%

- Check49 days agoChange DetectedRemoved the notice about a lapse in government funding and NIH operating status; no other content on the page was altered.SummaryDifference0.4%

- Check63 days agoChange DetectedThe new screenshot appears to include minor layout adjustments and wording tweaks without altering essential study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check92 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.